NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma
This study is currently recruiting participants.
Verified February 2013 by Noxxon Pharma AG
Sponsor:
Noxxon Pharma AG
Information provided by (Responsible Party):
Noxxon Pharma AG
ClinicalTrials.gov Identifier:
NCT01521533
First received: January 26, 2012
Last updated: February 22, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2015 |
| Estimated Primary Completion Date: | March 2014 (Final data collection date for primary outcome measure) |